Cleared Abbreviated

PRIME-XV FreezIS DMSO-Free MD

K231804 · Fujifilm Irvine Scientific · Gastroenterology & Urology
Nov 2023
Decision
142d
Days
Class 2
Risk

About This 510(k) Submission

K231804 is an FDA 510(k) clearance for the PRIME-XV FreezIS DMSO-Free MD, a Media, Culture, Ex Vivo, Tissue And Cell (Class II — Special Controls, product code NDS), submitted by Fujifilm Irvine Scientific (Santa Ana, US). The FDA issued a Cleared decision on November 9, 2023, 142 days after receiving the submission on June 20, 2023. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5885.

Submission Details

510(k) Number K231804 FDA.gov
FDA Decision Cleared SESE
Date Received June 20, 2023
Decision Date November 09, 2023
Days to Decision 142 days
Submission Type Abbreviated
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code NDS — Media, Culture, Ex Vivo, Tissue And Cell
Device Class Class II — Special Controls
CFR Regulation 21 CFR 876.5885

Similar Devices — NDS Media, Culture, Ex Vivo, Tissue And Cell

All 8
MSC SFM
K232543 · Yocon Biology Technology Company · Sep 2024
?MoFi? Cell Culture Basal Medium
K240247 · Duogenic Stemcells Corporation · Jul 2024
CT-STOR
K201789 · Energy Delivery Solutions · Sep 2021
OPTMIZER CTS T-CELL EXPANSION SERUM FREE MEDIUM
K113566 · Life Technologies, Inc. · Jun 2012
STEMPRO MSC SFM
K103302 · Life Technologies Corporation · Feb 2011
KNOCKOUT SR MEDIUM, KNOCKOUT SR XENOFREE MEDIUM MODEL 10828, 12618
K100616 · Life Technologies Corporation · May 2010